ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Recombinant Antibody Production Service Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-23X13442
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Recombinant Antibody Production Service Market Research Report 2023
BUY CHAPTERS

Global Recombinant Antibody Production Service Market Research Report 2025

Code: QYRE-Auto-23X13442
Report
May 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bon Opus Biosciences
Biomatik
Sino Biological
ProSci
GenScript
RayBiotech
Cygnus Technologies
Cusabio Technology
Absolute Antibody
Cayman Chemical
Creative-Biolabs
ProMab Biotechnologies
Leinco Technologies
R&D Systems
Rapid Novor
ACROBiosystems
evitria SA
Biointron Biological Inc.

Recombinant Antibody Production Service Market Size

The global market for Recombinant Antibody Production Service was valued at US$ 905 million in the year 2024 and is projected to reach a revised size of US$ 1319 million by 2031, growing at a CAGR of 5.6% during the forecast period.

Recombinant Antibody Production Service Market

Recombinant Antibody Production Service Market

North American market for Recombinant Antibody Production Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Recombinant Antibody Production Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Recombinant Antibody Production Service in Pharmaceutical is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Recombinant Antibody Production Service include evitria SA, Bon Opus Biosciences, Biomatik, Biointron Biological Inc., Sino Biological, ProSci Inc, GenScript, RayBiotech, Cygnus Technologies, Cusabio Technology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Recombinant Antibody Production Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Antibody Production Service.
The Recombinant Antibody Production Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Antibody Production Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Antibody Production Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Recombinant Antibody Production Service Market Report

Report Metric Details
Report Name Recombinant Antibody Production Service Market
Accounted market size in year US$ 905 million
Forecasted market size in 2031 US$ 1319 million
CAGR 5.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Pharmaceutical
  • Biotechnology Company
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company evitria SA, Bon Opus Biosciences, Biomatik, Biointron Biological Inc., Sino Biological, ProSci Inc, GenScript, RayBiotech, Cygnus Technologies, Cusabio Technology, Absolute Antibody, Cayman Chemical, Creative Biolabs, Promab Biotechnologies, Leinco Technologies, R&D Systems, Rapid Novor, ACROBiosystems
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Recombinant Antibody Production Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Recombinant Antibody Production Service Market growing?

Ans: The Recombinant Antibody Production Service Market witnessing a CAGR of 5.6% during the forecast period 2025-2031.

What is the Recombinant Antibody Production Service Market size in 2031?

Ans: The Recombinant Antibody Production Service Market size in 2031 will be US$ 1319 million.

Who are the main players in the Recombinant Antibody Production Service Market report?

Ans: The main players in the Recombinant Antibody Production Service Market are evitria SA, Bon Opus Biosciences, Biomatik, Biointron Biological Inc., Sino Biological, ProSci Inc, GenScript, RayBiotech, Cygnus Technologies, Cusabio Technology, Absolute Antibody, Cayman Chemical, Creative Biolabs, Promab Biotechnologies, Leinco Technologies, R&D Systems, Rapid Novor, ACROBiosystems

What are the Application segmentation covered in the Recombinant Antibody Production Service Market report?

Ans: The Applications covered in the Recombinant Antibody Production Service Market report are Pharmaceutical, Biotechnology Company, Others

What are the Type segmentation covered in the Recombinant Antibody Production Service Market report?

Ans: The Types covered in the Recombinant Antibody Production Service Market report are High-throughput Antibody Production Service, Small to Mid-scale Antibody Production Service, Large-scale Antibody Production Service, Chimeric Antibody Production Service, Antibody Fragment Production Service, Bispecific Antibody Production Service, Others

Recommended Reports

Antibody Services

Recombinant Proteins

Biopharma Services

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant Antibody Production Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 High-throughput Antibody Production Service
1.2.3 Small to Mid-scale Antibody Production Service
1.2.4 Large-scale Antibody Production Service
1.2.5 Chimeric Antibody Production Service
1.2.6 Antibody Fragment Production Service
1.2.7 Bispecific Antibody Production Service
1.2.8 Others
1.3 Market by Application
1.3.1 Global Recombinant Antibody Production Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical
1.3.3 Biotechnology Company
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Recombinant Antibody Production Service Market Perspective (2020-2031)
2.2 Global Recombinant Antibody Production Service Growth Trends by Region
2.2.1 Global Recombinant Antibody Production Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Recombinant Antibody Production Service Historic Market Size by Region (2020-2025)
2.2.3 Recombinant Antibody Production Service Forecasted Market Size by Region (2026-2031)
2.3 Recombinant Antibody Production Service Market Dynamics
2.3.1 Recombinant Antibody Production Service Industry Trends
2.3.2 Recombinant Antibody Production Service Market Drivers
2.3.3 Recombinant Antibody Production Service Market Challenges
2.3.4 Recombinant Antibody Production Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Recombinant Antibody Production Service Players by Revenue
3.1.1 Global Top Recombinant Antibody Production Service Players by Revenue (2020-2025)
3.1.2 Global Recombinant Antibody Production Service Revenue Market Share by Players (2020-2025)
3.2 Global Recombinant Antibody Production Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Recombinant Antibody Production Service Revenue
3.4 Global Recombinant Antibody Production Service Market Concentration Ratio
3.4.1 Global Recombinant Antibody Production Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant Antibody Production Service Revenue in 2024
3.5 Global Key Players of Recombinant Antibody Production Service Head office and Area Served
3.6 Global Key Players of Recombinant Antibody Production Service, Product and Application
3.7 Global Key Players of Recombinant Antibody Production Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Recombinant Antibody Production Service Breakdown Data by Type
4.1 Global Recombinant Antibody Production Service Historic Market Size by Type (2020-2025)
4.2 Global Recombinant Antibody Production Service Forecasted Market Size by Type (2026-2031)
5 Recombinant Antibody Production Service Breakdown Data by Application
5.1 Global Recombinant Antibody Production Service Historic Market Size by Application (2020-2025)
5.2 Global Recombinant Antibody Production Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Recombinant Antibody Production Service Market Size (2020-2031)
6.2 North America Recombinant Antibody Production Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Recombinant Antibody Production Service Market Size by Country (2020-2025)
6.4 North America Recombinant Antibody Production Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Recombinant Antibody Production Service Market Size (2020-2031)
7.2 Europe Recombinant Antibody Production Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Recombinant Antibody Production Service Market Size by Country (2020-2025)
7.4 Europe Recombinant Antibody Production Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Recombinant Antibody Production Service Market Size (2020-2031)
8.2 Asia-Pacific Recombinant Antibody Production Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Recombinant Antibody Production Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Recombinant Antibody Production Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Recombinant Antibody Production Service Market Size (2020-2031)
9.2 Latin America Recombinant Antibody Production Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Recombinant Antibody Production Service Market Size by Country (2020-2025)
9.4 Latin America Recombinant Antibody Production Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Recombinant Antibody Production Service Market Size (2020-2031)
10.2 Middle East & Africa Recombinant Antibody Production Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Recombinant Antibody Production Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Recombinant Antibody Production Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 evitria SA
11.1.1 evitria SA Company Details
11.1.2 evitria SA Business Overview
11.1.3 evitria SA Recombinant Antibody Production Service Introduction
11.1.4 evitria SA Revenue in Recombinant Antibody Production Service Business (2020-2025)
11.1.5 evitria SA Recent Development
11.2 Bon Opus Biosciences
11.2.1 Bon Opus Biosciences Company Details
11.2.2 Bon Opus Biosciences Business Overview
11.2.3 Bon Opus Biosciences Recombinant Antibody Production Service Introduction
11.2.4 Bon Opus Biosciences Revenue in Recombinant Antibody Production Service Business (2020-2025)
11.2.5 Bon Opus Biosciences Recent Development
11.3 Biomatik
11.3.1 Biomatik Company Details
11.3.2 Biomatik Business Overview
11.3.3 Biomatik Recombinant Antibody Production Service Introduction
11.3.4 Biomatik Revenue in Recombinant Antibody Production Service Business (2020-2025)
11.3.5 Biomatik Recent Development
11.4 Biointron Biological Inc.
11.4.1 Biointron Biological Inc. Company Details
11.4.2 Biointron Biological Inc. Business Overview
11.4.3 Biointron Biological Inc. Recombinant Antibody Production Service Introduction
11.4.4 Biointron Biological Inc. Revenue in Recombinant Antibody Production Service Business (2020-2025)
11.4.5 Biointron Biological Inc. Recent Development
11.5 Sino Biological
11.5.1 Sino Biological Company Details
11.5.2 Sino Biological Business Overview
11.5.3 Sino Biological Recombinant Antibody Production Service Introduction
11.5.4 Sino Biological Revenue in Recombinant Antibody Production Service Business (2020-2025)
11.5.5 Sino Biological Recent Development
11.6 ProSci Inc
11.6.1 ProSci Inc Company Details
11.6.2 ProSci Inc Business Overview
11.6.3 ProSci Inc Recombinant Antibody Production Service Introduction
11.6.4 ProSci Inc Revenue in Recombinant Antibody Production Service Business (2020-2025)
11.6.5 ProSci Inc Recent Development
11.7 GenScript
11.7.1 GenScript Company Details
11.7.2 GenScript Business Overview
11.7.3 GenScript Recombinant Antibody Production Service Introduction
11.7.4 GenScript Revenue in Recombinant Antibody Production Service Business (2020-2025)
11.7.5 GenScript Recent Development
11.8 RayBiotech
11.8.1 RayBiotech Company Details
11.8.2 RayBiotech Business Overview
11.8.3 RayBiotech Recombinant Antibody Production Service Introduction
11.8.4 RayBiotech Revenue in Recombinant Antibody Production Service Business (2020-2025)
11.8.5 RayBiotech Recent Development
11.9 Cygnus Technologies
11.9.1 Cygnus Technologies Company Details
11.9.2 Cygnus Technologies Business Overview
11.9.3 Cygnus Technologies Recombinant Antibody Production Service Introduction
11.9.4 Cygnus Technologies Revenue in Recombinant Antibody Production Service Business (2020-2025)
11.9.5 Cygnus Technologies Recent Development
11.10 Cusabio Technology
11.10.1 Cusabio Technology Company Details
11.10.2 Cusabio Technology Business Overview
11.10.3 Cusabio Technology Recombinant Antibody Production Service Introduction
11.10.4 Cusabio Technology Revenue in Recombinant Antibody Production Service Business (2020-2025)
11.10.5 Cusabio Technology Recent Development
11.11 Absolute Antibody
11.11.1 Absolute Antibody Company Details
11.11.2 Absolute Antibody Business Overview
11.11.3 Absolute Antibody Recombinant Antibody Production Service Introduction
11.11.4 Absolute Antibody Revenue in Recombinant Antibody Production Service Business (2020-2025)
11.11.5 Absolute Antibody Recent Development
11.12 Cayman Chemical
11.12.1 Cayman Chemical Company Details
11.12.2 Cayman Chemical Business Overview
11.12.3 Cayman Chemical Recombinant Antibody Production Service Introduction
11.12.4 Cayman Chemical Revenue in Recombinant Antibody Production Service Business (2020-2025)
11.12.5 Cayman Chemical Recent Development
11.13 Creative Biolabs
11.13.1 Creative Biolabs Company Details
11.13.2 Creative Biolabs Business Overview
11.13.3 Creative Biolabs Recombinant Antibody Production Service Introduction
11.13.4 Creative Biolabs Revenue in Recombinant Antibody Production Service Business (2020-2025)
11.13.5 Creative Biolabs Recent Development
11.14 Promab Biotechnologies
11.14.1 Promab Biotechnologies Company Details
11.14.2 Promab Biotechnologies Business Overview
11.14.3 Promab Biotechnologies Recombinant Antibody Production Service Introduction
11.14.4 Promab Biotechnologies Revenue in Recombinant Antibody Production Service Business (2020-2025)
11.14.5 Promab Biotechnologies Recent Development
11.15 Leinco Technologies
11.15.1 Leinco Technologies Company Details
11.15.2 Leinco Technologies Business Overview
11.15.3 Leinco Technologies Recombinant Antibody Production Service Introduction
11.15.4 Leinco Technologies Revenue in Recombinant Antibody Production Service Business (2020-2025)
11.15.5 Leinco Technologies Recent Development
11.16 R&D Systems
11.16.1 R&D Systems Company Details
11.16.2 R&D Systems Business Overview
11.16.3 R&D Systems Recombinant Antibody Production Service Introduction
11.16.4 R&D Systems Revenue in Recombinant Antibody Production Service Business (2020-2025)
11.16.5 R&D Systems Recent Development
11.17 Rapid Novor
11.17.1 Rapid Novor Company Details
11.17.2 Rapid Novor Business Overview
11.17.3 Rapid Novor Recombinant Antibody Production Service Introduction
11.17.4 Rapid Novor Revenue in Recombinant Antibody Production Service Business (2020-2025)
11.17.5 Rapid Novor Recent Development
11.18 ACROBiosystems
11.18.1 ACROBiosystems Company Details
11.18.2 ACROBiosystems Business Overview
11.18.3 ACROBiosystems Recombinant Antibody Production Service Introduction
11.18.4 ACROBiosystems Revenue in Recombinant Antibody Production Service Business (2020-2025)
11.18.5 ACROBiosystems Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Bon Opus Biosciences
Biomatik
Sino Biological
ProSci
GenScript
RayBiotech
Cygnus Technologies
Cusabio Technology
Absolute Antibody
Cayman Chemical
Creative-Biolabs
ProMab Biotechnologies
Leinco Technologies
R&D Systems
Rapid Novor
ACROBiosystems
evitria SA
Biointron Biological Inc.
List of Tables
 Table 1. Global Recombinant Antibody Production Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of High-throughput Antibody Production Service
 Table 3. Key Players of Small to Mid-scale Antibody Production Service
 Table 4. Key Players of Large-scale Antibody Production Service
 Table 5. Key Players of Chimeric Antibody Production Service
 Table 6. Key Players of Antibody Fragment Production Service
 Table 7. Key Players of Bispecific Antibody Production Service
 Table 8. Key Players of Others
 Table 9. Global Recombinant Antibody Production Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global Recombinant Antibody Production Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 11. Global Recombinant Antibody Production Service Market Size by Region (2020-2025) & (US$ Million)
 Table 12. Global Recombinant Antibody Production Service Market Share by Region (2020-2025)
 Table 13. Global Recombinant Antibody Production Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 14. Global Recombinant Antibody Production Service Market Share by Region (2026-2031)
 Table 15. Recombinant Antibody Production Service Market Trends
 Table 16. Recombinant Antibody Production Service Market Drivers
 Table 17. Recombinant Antibody Production Service Market Challenges
 Table 18. Recombinant Antibody Production Service Market Restraints
 Table 19. Global Recombinant Antibody Production Service Revenue by Players (2020-2025) & (US$ Million)
 Table 20. Global Recombinant Antibody Production Service Market Share by Players (2020-2025)
 Table 21. Global Top Recombinant Antibody Production Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Antibody Production Service as of 2024)
 Table 22. Ranking of Global Top Recombinant Antibody Production Service Companies by Revenue (US$ Million) in 2024
 Table 23. Global 5 Largest Players Market Share by Recombinant Antibody Production Service Revenue (CR5 and HHI) & (2020-2025)
 Table 24. Global Key Players of Recombinant Antibody Production Service, Headquarters and Area Served
 Table 25. Global Key Players of Recombinant Antibody Production Service, Product and Application
 Table 26. Global Key Players of Recombinant Antibody Production Service, Date of Enter into This Industry
 Table 27. Mergers & Acquisitions, Expansion Plans
 Table 28. Global Recombinant Antibody Production Service Market Size by Type (2020-2025) & (US$ Million)
 Table 29. Global Recombinant Antibody Production Service Revenue Market Share by Type (2020-2025)
 Table 30. Global Recombinant Antibody Production Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 31. Global Recombinant Antibody Production Service Revenue Market Share by Type (2026-2031)
 Table 32. Global Recombinant Antibody Production Service Market Size by Application (2020-2025) & (US$ Million)
 Table 33. Global Recombinant Antibody Production Service Revenue Market Share by Application (2020-2025)
 Table 34. Global Recombinant Antibody Production Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 35. Global Recombinant Antibody Production Service Revenue Market Share by Application (2026-2031)
 Table 36. North America Recombinant Antibody Production Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. North America Recombinant Antibody Production Service Market Size by Country (2020-2025) & (US$ Million)
 Table 38. North America Recombinant Antibody Production Service Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Europe Recombinant Antibody Production Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Europe Recombinant Antibody Production Service Market Size by Country (2020-2025) & (US$ Million)
 Table 41. Europe Recombinant Antibody Production Service Market Size by Country (2026-2031) & (US$ Million)
 Table 42. Asia-Pacific Recombinant Antibody Production Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Asia-Pacific Recombinant Antibody Production Service Market Size by Region (2020-2025) & (US$ Million)
 Table 44. Asia-Pacific Recombinant Antibody Production Service Market Size by Region (2026-2031) & (US$ Million)
 Table 45. Latin America Recombinant Antibody Production Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Latin America Recombinant Antibody Production Service Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Latin America Recombinant Antibody Production Service Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Middle East & Africa Recombinant Antibody Production Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 49. Middle East & Africa Recombinant Antibody Production Service Market Size by Country (2020-2025) & (US$ Million)
 Table 50. Middle East & Africa Recombinant Antibody Production Service Market Size by Country (2026-2031) & (US$ Million)
 Table 51. evitria SA Company Details
 Table 52. evitria SA Business Overview
 Table 53. evitria SA Recombinant Antibody Production Service Product
 Table 54. evitria SA Revenue in Recombinant Antibody Production Service Business (2020-2025) & (US$ Million)
 Table 55. evitria SA Recent Development
 Table 56. Bon Opus Biosciences Company Details
 Table 57. Bon Opus Biosciences Business Overview
 Table 58. Bon Opus Biosciences Recombinant Antibody Production Service Product
 Table 59. Bon Opus Biosciences Revenue in Recombinant Antibody Production Service Business (2020-2025) & (US$ Million)
 Table 60. Bon Opus Biosciences Recent Development
 Table 61. Biomatik Company Details
 Table 62. Biomatik Business Overview
 Table 63. Biomatik Recombinant Antibody Production Service Product
 Table 64. Biomatik Revenue in Recombinant Antibody Production Service Business (2020-2025) & (US$ Million)
 Table 65. Biomatik Recent Development
 Table 66. Biointron Biological Inc. Company Details
 Table 67. Biointron Biological Inc. Business Overview
 Table 68. Biointron Biological Inc. Recombinant Antibody Production Service Product
 Table 69. Biointron Biological Inc. Revenue in Recombinant Antibody Production Service Business (2020-2025) & (US$ Million)
 Table 70. Biointron Biological Inc. Recent Development
 Table 71. Sino Biological Company Details
 Table 72. Sino Biological Business Overview
 Table 73. Sino Biological Recombinant Antibody Production Service Product
 Table 74. Sino Biological Revenue in Recombinant Antibody Production Service Business (2020-2025) & (US$ Million)
 Table 75. Sino Biological Recent Development
 Table 76. ProSci Inc Company Details
 Table 77. ProSci Inc Business Overview
 Table 78. ProSci Inc Recombinant Antibody Production Service Product
 Table 79. ProSci Inc Revenue in Recombinant Antibody Production Service Business (2020-2025) & (US$ Million)
 Table 80. ProSci Inc Recent Development
 Table 81. GenScript Company Details
 Table 82. GenScript Business Overview
 Table 83. GenScript Recombinant Antibody Production Service Product
 Table 84. GenScript Revenue in Recombinant Antibody Production Service Business (2020-2025) & (US$ Million)
 Table 85. GenScript Recent Development
 Table 86. RayBiotech Company Details
 Table 87. RayBiotech Business Overview
 Table 88. RayBiotech Recombinant Antibody Production Service Product
 Table 89. RayBiotech Revenue in Recombinant Antibody Production Service Business (2020-2025) & (US$ Million)
 Table 90. RayBiotech Recent Development
 Table 91. Cygnus Technologies Company Details
 Table 92. Cygnus Technologies Business Overview
 Table 93. Cygnus Technologies Recombinant Antibody Production Service Product
 Table 94. Cygnus Technologies Revenue in Recombinant Antibody Production Service Business (2020-2025) & (US$ Million)
 Table 95. Cygnus Technologies Recent Development
 Table 96. Cusabio Technology Company Details
 Table 97. Cusabio Technology Business Overview
 Table 98. Cusabio Technology Recombinant Antibody Production Service Product
 Table 99. Cusabio Technology Revenue in Recombinant Antibody Production Service Business (2020-2025) & (US$ Million)
 Table 100. Cusabio Technology Recent Development
 Table 101. Absolute Antibody Company Details
 Table 102. Absolute Antibody Business Overview
 Table 103. Absolute Antibody Recombinant Antibody Production Service Product
 Table 104. Absolute Antibody Revenue in Recombinant Antibody Production Service Business (2020-2025) & (US$ Million)
 Table 105. Absolute Antibody Recent Development
 Table 106. Cayman Chemical Company Details
 Table 107. Cayman Chemical Business Overview
 Table 108. Cayman Chemical Recombinant Antibody Production Service Product
 Table 109. Cayman Chemical Revenue in Recombinant Antibody Production Service Business (2020-2025) & (US$ Million)
 Table 110. Cayman Chemical Recent Development
 Table 111. Creative Biolabs Company Details
 Table 112. Creative Biolabs Business Overview
 Table 113. Creative Biolabs Recombinant Antibody Production Service Product
 Table 114. Creative Biolabs Revenue in Recombinant Antibody Production Service Business (2020-2025) & (US$ Million)
 Table 115. Creative Biolabs Recent Development
 Table 116. Promab Biotechnologies Company Details
 Table 117. Promab Biotechnologies Business Overview
 Table 118. Promab Biotechnologies Recombinant Antibody Production Service Product
 Table 119. Promab Biotechnologies Revenue in Recombinant Antibody Production Service Business (2020-2025) & (US$ Million)
 Table 120. Promab Biotechnologies Recent Development
 Table 121. Leinco Technologies Company Details
 Table 122. Leinco Technologies Business Overview
 Table 123. Leinco Technologies Recombinant Antibody Production Service Product
 Table 124. Leinco Technologies Revenue in Recombinant Antibody Production Service Business (2020-2025) & (US$ Million)
 Table 125. Leinco Technologies Recent Development
 Table 126. R&D Systems Company Details
 Table 127. R&D Systems Business Overview
 Table 128. R&D Systems Recombinant Antibody Production Service Product
 Table 129. R&D Systems Revenue in Recombinant Antibody Production Service Business (2020-2025) & (US$ Million)
 Table 130. R&D Systems Recent Development
 Table 131. Rapid Novor Company Details
 Table 132. Rapid Novor Business Overview
 Table 133. Rapid Novor Recombinant Antibody Production Service Product
 Table 134. Rapid Novor Revenue in Recombinant Antibody Production Service Business (2020-2025) & (US$ Million)
 Table 135. Rapid Novor Recent Development
 Table 136. ACROBiosystems Company Details
 Table 137. ACROBiosystems Business Overview
 Table 138. ACROBiosystems Recombinant Antibody Production Service Product
 Table 139. ACROBiosystems Revenue in Recombinant Antibody Production Service Business (2020-2025) & (US$ Million)
 Table 140. ACROBiosystems Recent Development
 Table 141. Research Programs/Design for This Report
 Table 142. Key Data Information from Secondary Sources
 Table 143. Key Data Information from Primary Sources
 Table 144. Authors List of This Report


List of Figures
 Figure 1. Recombinant Antibody Production Service Picture
 Figure 2. Global Recombinant Antibody Production Service Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Recombinant Antibody Production Service Market Share by Type: 2024 VS 2031
 Figure 4. High-throughput Antibody Production Service Features
 Figure 5. Small to Mid-scale Antibody Production Service Features
 Figure 6. Large-scale Antibody Production Service Features
 Figure 7. Chimeric Antibody Production Service Features
 Figure 8. Antibody Fragment Production Service Features
 Figure 9. Bispecific Antibody Production Service Features
 Figure 10. Others Features
 Figure 11. Global Recombinant Antibody Production Service Market Size by Application (2020-2031) & (US$ Million)
 Figure 12. Global Recombinant Antibody Production Service Market Share by Application: 2024 VS 2031
 Figure 13. Pharmaceutical Case Studies
 Figure 14. Biotechnology Company Case Studies
 Figure 15. Others Case Studies
 Figure 16. Recombinant Antibody Production Service Report Years Considered
 Figure 17. Global Recombinant Antibody Production Service Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 18. Global Recombinant Antibody Production Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 19. Global Recombinant Antibody Production Service Market Share by Region: 2024 VS 2031
 Figure 20. Global Recombinant Antibody Production Service Market Share by Players in 2024
 Figure 21. Global Top Recombinant Antibody Production Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Antibody Production Service as of 2024)
 Figure 22. The Top 10 and 5 Players Market Share by Recombinant Antibody Production Service Revenue in 2024
 Figure 23. North America Recombinant Antibody Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. North America Recombinant Antibody Production Service Market Share by Country (2020-2031)
 Figure 25. United States Recombinant Antibody Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Canada Recombinant Antibody Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Recombinant Antibody Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe Recombinant Antibody Production Service Market Share by Country (2020-2031)
 Figure 29. Germany Recombinant Antibody Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. France Recombinant Antibody Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. U.K. Recombinant Antibody Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Italy Recombinant Antibody Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Russia Recombinant Antibody Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Nordic Countries Recombinant Antibody Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Recombinant Antibody Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Recombinant Antibody Production Service Market Share by Region (2020-2031)
 Figure 37. China Recombinant Antibody Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Japan Recombinant Antibody Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. South Korea Recombinant Antibody Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Recombinant Antibody Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. India Recombinant Antibody Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Australia Recombinant Antibody Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Recombinant Antibody Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America Recombinant Antibody Production Service Market Share by Country (2020-2031)
 Figure 45. Mexico Recombinant Antibody Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Brazil Recombinant Antibody Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Recombinant Antibody Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa Recombinant Antibody Production Service Market Share by Country (2020-2031)
 Figure 49. Turkey Recombinant Antibody Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Recombinant Antibody Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. UAE Recombinant Antibody Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. evitria SA Revenue Growth Rate in Recombinant Antibody Production Service Business (2020-2025)
 Figure 53. Bon Opus Biosciences Revenue Growth Rate in Recombinant Antibody Production Service Business (2020-2025)
 Figure 54. Biomatik Revenue Growth Rate in Recombinant Antibody Production Service Business (2020-2025)
 Figure 55. Biointron Biological Inc. Revenue Growth Rate in Recombinant Antibody Production Service Business (2020-2025)
 Figure 56. Sino Biological Revenue Growth Rate in Recombinant Antibody Production Service Business (2020-2025)
 Figure 57. ProSci Inc Revenue Growth Rate in Recombinant Antibody Production Service Business (2020-2025)
 Figure 58. GenScript Revenue Growth Rate in Recombinant Antibody Production Service Business (2020-2025)
 Figure 59. RayBiotech Revenue Growth Rate in Recombinant Antibody Production Service Business (2020-2025)
 Figure 60. Cygnus Technologies Revenue Growth Rate in Recombinant Antibody Production Service Business (2020-2025)
 Figure 61. Cusabio Technology Revenue Growth Rate in Recombinant Antibody Production Service Business (2020-2025)
 Figure 62. Absolute Antibody Revenue Growth Rate in Recombinant Antibody Production Service Business (2020-2025)
 Figure 63. Cayman Chemical Revenue Growth Rate in Recombinant Antibody Production Service Business (2020-2025)
 Figure 64. Creative Biolabs Revenue Growth Rate in Recombinant Antibody Production Service Business (2020-2025)
 Figure 65. Promab Biotechnologies Revenue Growth Rate in Recombinant Antibody Production Service Business (2020-2025)
 Figure 66. Leinco Technologies Revenue Growth Rate in Recombinant Antibody Production Service Business (2020-2025)
 Figure 67. R&D Systems Revenue Growth Rate in Recombinant Antibody Production Service Business (2020-2025)
 Figure 68. Rapid Novor Revenue Growth Rate in Recombinant Antibody Production Service Business (2020-2025)
 Figure 69. ACROBiosystems Revenue Growth Rate in Recombinant Antibody Production Service Business (2020-2025)
 Figure 70. Bottom-up and Top-down Approaches for This Report
 Figure 71. Data Triangulation
 Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Recombinant Antibody Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Custom Recombinant Antibody Production Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antibody Production Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Recombinant Antibody Expression Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Custom Recombinant Antibody Conversion Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antibody Development and Production Services Market Research Report 2025
Global Custom Antibody Production Services Market Research Report 2025
Global Recombinant Protein Service Market Research Report 2025
Global High Throughput Recombinant Antibody Production Service Market Research Report 2024
Custom Antibody Development Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Recombinant Protein Purification Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Antibody IgG Production Services Market Research Report 2025
Custom Recombinant Protein Expression Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antibody Sequencing Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Antibodies rAbs Market Research Report 2024
Recombinant Protein Therapeutics Market
Global Antibody Assay Service Market Research Report 2025
Recombinant Human Fibronectin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Recombinant Human Dnase Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Recombinant Protein Expression and Purification Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions